Sarah Girdwood to Cost-Benefit Analysis
This is a "connection" page, showing publications Sarah Girdwood has written about Cost-Benefit Analysis.
Connection Strength
0,290
-
Point-of-care assays for early infant diagnosis in Zimbabwe. Lancet HIV. 2019 03; 6(3):e146-e147.
Score: 0,144
-
Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya. Trials. 2024 May 21; 25(1):331.
Score: 0,052
-
Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis. BMJ Open. 2024 Feb 27; 14(2):e078674.
Score: 0,051
-
Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa. Health Policy Plan. 2021 Nov 11; 36(10):1545-1551.
Score: 0,044